Fishman Jay A LTD Arcutis Biotherapeutics, Inc. Transaction History
Fishman Jay A LTD
- $901 Million
- Q1 2025
A detailed history of Fishman Jay A LTD transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Fishman Jay A LTD holds 533,150 shares of ARQT stock, worth $7.79 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
533,150
Previous 536,400
0.61%
Holding current value
$7.79 Million
Previous $7.47 Million
11.59%
% of portfolio
0.93%
Previous 0.7%
Shares
13 transactions
Others Institutions Holding ARQT
# of Institutions
224Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$180 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$167 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$160 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$128 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$126 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $879M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...